OMICS International is glad to welcome all the interested participants to its 4th International Conference on Blood Malignancies and Treatment during April 18-20, 2016 at Dubai, UAE. The conference will be organized around the theme “Conquering blood cancer with contemporary precision therapeutics and restorative approaches”. Blood Malignancies 2016 welcomes the haematologists, immunologists, pathologists, oncologists, research scholars, industrial professionals and student delegates from biomedical and healthcare sectors to be a part of it.
Blood cancer is a type of cancer or tumor. Blood cancer affects the blood, bone marrow, lymph, and lymphatic system, sometimes more than one body part gets affected. It affects the production and function of your blood cells. Most of these cancers start in your bone marrow where blood is produced. Billions of people are suffering from blood cancers and millions are dying every year across the globe.
Blood Malignancies 2016 will be an initiative to find the weapon to fight against the dreadful blood cancers, to protect and save lives. Discussions will be focused on the different types of blood cancers, possibility of early detection and treatment at the advanced stages of these cancers to prolong life.
For more details visit http://bloodmalignancies.conferenceseries.com/
OMICS International has an enhanced and highlighted features of scientific partnerships and alliances with development agencies, Institutes, leading research organizations, non-government organizations, and other entities to promote the development-oriented research across the globe through live streaming, B2B and Scientific Meetings. OMICS International’s Medical Conferences provides an excellent opportunity for the budding scientists and young researchers through its special initiatives like Young Researcher Forum, Poster Presentation and E-poster.
OMICS International Organizes 300+ Scientific Conferences every year across USA, Europe & Asia. Besides 500 Peer reviewed, Open Access Journals, OMICS International has collaborated with more than 1000 Scientific Associations and institutions worldwide to promote information on health care and technologies. These journals are enjoying the support of over 5 million readers; a team of 30,000 eminent scholars are providing editorial support.
Blood Malignancies 2016 is going to take place in Dubai, UAE the largest and most populous City of UAE. It will be a great opportunity for the participants to explore this beautiful city which comprises of beautiful architectural innovations as well as contemporary technological tourist attractions besides gaining and sharing knowledge in an international platform.
Unfortunately, blood cancer affects a large number of people. Every 20 minutes, one person in UK is detected with blood cancer, 70 people a day, and 25,000 people a year. According to the CDC, cancer is the second leading cause of mortality, causing 584,881 deaths worldwide in 2013. Early diagnosis is the key to prevent the rising number of cancer-related deaths. The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms such as next-generation sequencing, DNA microarrays, and polymerase chain reaction (PCR). Moreover, the market has seen the advent of hybrid imaging instruments with enhanced accuracy, such as PET/CT and SPECT/CT. These advancements have augmented the growth of the cancer diagnostics market. The global cancer diagnostics market is expected to reach $13.1 Billion in 2020 from an estimated $7.1 Billion in 2015, growing at a CAGR of 12.9%. The global tumor ablation market is poised to grow at a CAGR of 11.5% during 2014-2019, and is expected to reach a value of 462.0 Million in 2019.